Related references
Note: Only part of the references are listed.Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients
Francois Schiele et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany
Ingo Ahrens et al.
ADVANCES IN THERAPY (2021)
Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment
Fabien Picard et al.
CURRENT ATHEROSCLEROSIS REPORTS (2021)
Clinical review on triglycerides
Ulrich Laufs et al.
EUROPEAN HEART JOURNAL (2020)
Eligibility and Preventive Potential for New Evidence-Based Cardiovascular Drugs in Secondary Prevention
Martin Bodtker Mortensen et al.
JAMA CARDIOLOGY (2020)
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial: Insight From the Veterans Affairs Healthcare System
Xiaoming Jia et al.
CIRCULATION (2019)
Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it
Nick S. R. Lan et al.
DIABETES OBESITY & METABOLISM (2019)
Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease
Fabien Picard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Effects of Icosapent Ethyl on Total Ischemic Events From REDUCE-IT
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
Carl E. Orringer et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey
Wenjun Fan et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Arthur Darmon et al.
EUROPEAN HEART JOURNAL (2018)
High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk
Peter P. Toth et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial
Deepak L. Bhatt et al.
CLINICAL CARDIOLOGY (2017)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
Gregory G. Schwartz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease
Ole Faergeman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
One-year cardiovascular event rates in outpatients with atherothrombosis
Ph. Gabriel Steg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
External validity of clinical trials in acute myocardial infarction
Philippe Gabriel Steg et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
The REduction of Atherothrombosis for Continued Health (REACH) Registry:: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design
EM Ohman et al.
AMERICAN HEART JOURNAL (2006)
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
DL Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Low-density lipoprotein cholesterol estimation by a new formula in Indian population
S Anandaraja et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Share Paper
